Annabelle Bozarth started taking Vimizim, BioMarin Pharmaceutical's enzyme replacement therapy for MPS IVA, in a Phase III clinical trial.
http://ift.tt/1f5uEM9
http://ift.tt/1f5uEM9
Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment